Mild to moderate male pattern baldness (androgenic alopecia) study to help shape potential future treatments for hair loss now enrolling in multiple locations.
Flyer
QR Code
INDICATION (DISEASE)
Mild to moderate male pattern baldness (androgenic alopecia)
about the study
This study involves an investigational microinjection product.
The study consists of 10 visits over approximately 6 months.
ELIGIBILITY REQUIREMENTS
You are a male between 18-45 years of age.
You are not currently undergoing any treatments related to hair or scalp issues.
Mild to moderate hair loss due to male pattern baldness.